You are here :
Home
Healthcare
Payment Link for Sterlitech Corporation - Track etched Membrane Market & Pharmaceutical Filtration Market
Drug formulations
ATC
Global Antiinfectives for Systemic Use Market Research Report
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
Global Inactivated Vaccines Market The Global Inactivated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $1958 million in 2013 and expected to be $2974million by 2018 at a CAGR of 8.7%. Inactivated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac. |
Upcoming |
|
|
Global Sub-unit Vaccines Market The Global Subunit Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $91 million in 2013 and expected to be $134 million by 2018 at a CAGR of 8.1%. Subunit Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac. |
Upcoming |
|
|
Global Toxoid Vaccines Market The Global Toxoid Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $468.1 million in 2013 and expected to be $644.8 million by 2018 at a CAGR of 6.6%. Toxoid Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac. |
Upcoming |
|
|
Global Conjugate Vaccines Market The global conjugate animal vaccine market is mainly driven by the growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans. It was valued at $201.1 million in 2013 and is expected to reach $305.2 million by 2018 at a CAGR of 8.7% during the forecast period. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac. |
Upcoming |
|
|
Global Recombinant Vaccines Market The Global Recombinant Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $368.9 million in 2013 and expected to be $550.8 million by 2018 at a CAGR of 8.3%. Recombinant Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac. |
Upcoming |
|
|
Global Dna Vaccines Market The global DNA animal vaccine market is mainly driven by growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans. It was valued at $142.5 million in 2013 and is expected to reach $232.4 million by 2018, at a CAGR of 10.3% for the forecast period. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac. |
Upcoming |
|
|
Animal Vaccines Animal Vaccines and Bacterial vaccines, Viral vaccines, |
Upcoming |
|
|
Synthetic Vaccines Synthetic Vaccines and Live Attenuated Vaccines (LAV), |
Upcoming |
|
|
Dentritic Vaccines Dentritic Vaccines and Live Attenuated Vaccines (LAV), |
Upcoming |
|
|
Antimycobacterial Aminosalicylic acid and derivatives Antimycobacterial Aminosalicylic acid and derivatives and its peer markets - E-Clinical Trial Solutions, |
Upcoming |
|
|
Antimycobacterial Antibiotics Antimycobacterial Antibiotics and its peer markets - Combinations of drugs for treatment of tuberculosis, E-Clinical Trial Solutions, |
Upcoming |
|
|
Antimycobacterial Hydrazides Antimycobacterial Hydrazides and its peer markets - Proteomics, |
Upcoming |
|
|
Antimycobacterial Thiocarbamide derivatives Antimycobacterial Thiocarbamide derivatives and its peer markets - E-Clinical Trial Solutions, |
Upcoming |
|
|
Canine Vaccines Canine Vaccines and Feline Vaccines adds up to total Companion animal vaccines market. Canine Vaccines can be segmented by Types, Geographies,... |
Upcoming |
|
|
Feline Vaccines Feline Vaccines and Canine Vaccines adds up to total Companion animal vaccines market. Feline Vaccines can be segmented by Types, Geographies,... |
Upcoming |
|
|
Bovine Vaccines Bovine Vaccines and Small Ruminant Vaccines adds up to total Livestock market. Bovine Vaccines can be segmented by Types, Geographies,... |
Upcoming |
|
|
Small Ruminant Vaccines Small Ruminant Vaccines and Bovine Vaccines adds up to total Livestock market. Small Ruminant Vaccines can be segmented by Types, Geographies,... |
Upcoming |
|
|
Infectious Bronchitis Infectious Bronchitis and Gumboro Disease, Avian Influenza, |
Upcoming |
|
|
Gumboro Disease Gumboro Disease and Infectious Bronchitis, Avian Influenza,... |
Upcoming |
|
|
Avian Influenza Avian Influenza and Infectious Bronchitis, Gumboro Disease,... |
Upcoming |
Antiinfectives for Systemic Use
